Purchase Order 75F40123P00201
- Not listed
- The Food and Drug Administration awarded a $206,010 firm fixed-price purchase order to Becton, Dickinson and Company (BD Biosciences division) on July 14, 2020, for a BD FACSAria II SORP Cell Sorter (Serial Number P69500102) to be delivered to San Jose, California. This award was made without a small business set-aside and represents a single equipment acquisition under a standard purchase order vehicle with an ultimate completion date of September 3, 2025. The FACSAria II is a sophisticated...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order valued at $61,260.74 for a flow cytometer system and associated service agreement by the Food and Drug Administration. The contract, awarded July 18, 2014, with an ultimate completion date of August 31, 2019, represents a firm fixed-price delivery order with no small business set-aside. The place of performance is San Jose, California. This award provides the FDA with advanced...
- The U.S. Food and Drug Administration (FDA) awarded a $431,505.49 firm-fixed-price delivery order contract to Becton, Dickinson and Company (BD) for a flow cytometry system with 5 one-year post-warranty maintenance options. The contract is not set aside. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications. The delivery order likely supports the FDA's work in evaluating and approving medical...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $776,765.60 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of one BD Biosciences FACSDISCOVER 8S Cell Sorter instrument. Performance will take place in San Jose, California over a period of approximately two months from September 2023 through November 2023. BD Biosciences...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price delivery order contract to Becton, Dickinson And Company (BD) for the inspection and maintenance of a FACSARIAII cell sorter. The contract has a ceiling value of $79,807.65 and runs through March 31, 2016. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics technologies. This...
- The Department of Health and Human Services Food and Drug Administration awarded a fixed-price purchase order to Becton, Dickinson and Company (BD) to provide maintenance and support services for a BD FACSAria II cell sorter at the FDA's Center for Biologics Evaluation and Research (CBER) in Silver Spring, Maryland. The $107,568.00 contract has a completion date of December 14, 2022 and does not utilize a small business set-aside. BD, a leading medical technology manufacturer, will provide...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $521,896 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems And Reagents Division for an integrated BD FACSAria Fusion cell sorter and biosafety cabinet solution. The solicitation sought a cell sorter capable of 4-way tube sorting and automatic cell deposition into 96-well plates at rates over 50,000 events per second...
- This delivery order, issued by the Food and Drug Administration on February 17, 2021, awards Becton, Dickinson and Company (BD Biosciences division) $33,516.73 for corrective/remedial repair and preventive maintenance services on an LSRII flow cytometer, high-throughput sampler, and FACS flow supply system located in San Jose, California. The contract was executed under the Multiple Award Schedule vehicle and utilized firm fixed price terms without a small business set-aside. This...
- The U.S. Food and Drug Administration awarded a $62,449.13 delivery order contract to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for preventative and corrective/remedial maintenance repair services for a FACSCanto II Flow Cytometer and high-throughput sampler. This firm fixed-price delivery order was awarded on August 23, 2018, with an ultimate completion date of September 13, 2023, with performance to occur in Jefferson, Arkansas. The contract...
- The Food and Drug Administration awarded a delivery order valued at $33,724.80 to Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, for preventive maintenance and repair services on a BD LSR II Flow Cytometer with 488 laser and high throughput sampler equipment located at the FDA's Silver Spring, Maryland facility. The contract was awarded on September 23, 2019, on a firm fixed price basis without small business set-aside designation, with an ultimate...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order valued at $750,244.75 to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a Multiparameter Flow Cytometric Cell Sorter with Spectral Analysis and Cell Imaging (Imaging Cell Sorter). The equipment will be delivered to and utilized by the FDA's Center for Biologics Evaluation and Research facility in San Jose, California, under the terms of the order issued on July 31, 2023 through completion on October 29, 2023. The original solicitation sought quotes for a cell sorter meeting technical specifications including lasers, detectors, sample handling, and sort collection capabilities to support the FDA's review of biologics and devices. There was no set-aside designation for this award to the prime contractor Becton, Dickinson and Company for the requested cell sorting equipment.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Multiparameter Flow Cytometric Cell Sorter with Spectral Analysis and Cell Imaging | 75F40123Q116864 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 3/17/23, 9:29 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $750.2k | 7/31/23 |